PVLA: FDA Starts Review
Palvella Therapeutics announces FDA rolling review of its new drug application for Qtorin Rapamycin
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Palvella Therapeutics announces FDA rolling review of its new drug application for Qtorin Rapamycin